R. Shen

Resource Genomic , Pathway Networ k , and Immunologic Features Distinguishing Squamous Carcinomas Graphical

Joshua M. Stuart, Joshua D. Campbell, Christopher K. Wong, 2018 .

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations.

M. Kris, C. Azzoli, Gregory Riely, 2009, Journal of Clinical Oncology.

Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.

Joshua M. Stuart, Joshua D. Campbell, Christopher K. Wong, 2018, Cell reports.